LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Home・Список акций・Dare Bioscience Inc

Dare Bioscience Inc

Закрыт

1.67 -0.6

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.67

Макс.

1.7

Рекомендации
By TipRanks
Рекомендации	Покупка
Прогноз на 12 месяцев	+605.88% upside

Dare Bioscience Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

15 февр. 2026 г., 23:21 UTC

Приобретения, слияния, поглощения

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 февр. 2026 г., 23:45 UTC

Обсуждения рынка

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 февр. 2026 г., 23:40 UTC

Обсуждения рынка

Gold Falls on Possible Position Adjustments -- Market Talk

15 февр. 2026 г., 23:06 UTC

Отчет

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 февр. 2026 г., 23:04 UTC

Отчет

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 февр. 2026 г., 23:04 UTC

Отчет

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 февр. 2026 г., 23:01 UTC

Отчет

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 февр. 2026 г., 23:01 UTC

Отчет

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 февр. 2026 г., 22:58 UTC

Отчет

Warner Bros. Lands Ninth Straight Box Office Winner With 'Wuthering Heights' -- Barrons.com

15 февр. 2026 г., 22:53 UTC

Приобретения, слияния, поглощения

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 февр. 2026 г., 22:53 UTC

Приобретения, слияния, поглощения

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 февр. 2026 г., 22:52 UTC

Приобретения, слияния, поглощения

Qube Shareholders to Receive A$5.20/Share in Cash

15 февр. 2026 г., 22:52 UTC

Приобретения, слияния, поглощения

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 февр. 2026 г., 21:35 UTC

Отчет

Warner Bros. Lands Ninth Straight Box Office Winner With 'Wuthering Heights' -- Barrons.com

15 февр. 2026 г., 20:48 UTC

Отчет

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

15 февр. 2026 г., 20:47 UTC

Отчет

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

15 февр. 2026 г., 20:46 UTC

Отчет

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

15 февр. 2026 г., 20:45 UTC

Отчет

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

15 февр. 2026 г., 20:44 UTC

Отчет

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

15 февр. 2026 г., 20:44 UTC

Отчет

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

15 февр. 2026 г., 20:43 UTC

Отчет

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

15 февр. 2026 г., 20:42 UTC

Отчет

BlueScope Net Debt A$2.2 Million at Dec. 31

15 февр. 2026 г., 20:42 UTC

Отчет

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

15 февр. 2026 г., 20:41 UTC

Отчет

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

15 февр. 2026 г., 20:40 UTC

Отчет

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

15 февр. 2026 г., 20:40 UTC

Отчет

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

15 февр. 2026 г., 20:39 UTC

Отчет

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

15 февр. 2026 г., 20:38 UTC

Отчет

BlueScope Targeting A$1.30/Share Annual Ordinary Dividend

15 февр. 2026 г., 20:37 UTC

Отчет

BlueScope Targeting Shareholder Returns of A$3.00/Share in 2026

15 февр. 2026 г., 20:37 UTC

Отчет

BlueScope Interim Dividend 65 Australian Cents/Share

Сравнение c конкурентами

Изменение цены

Dare Bioscience Inc Прогноз

Целевая цена

By TipRanks

605.88% рост

Прогноз на 12 месяцев

Средняя 12 USD 605.88%

Максимум 12 USD

Минимум 12 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для Dare Bioscience Inc на следующие 12 месяцев – Данные за последние 3 месяца.